SPL Quarterly Activities/Appendix 4C Cash Flow Report 30/04/24 PRICE SENSITIVE download Created with Sketch. 341.27KB Share SPL Change in Director's Interest Notice - R Thomas 17/04/24 download Created with Sketch. 153.92KB Share SPL Change in Director's Interest Notice - R Basser 16/04/24 download Created with Sketch. 145.3KB Share SPL Change in Director's Interest Notice - R Thomas 15/04/24 download Created with Sketch. 144.02KB Share SPL Investor Webinar Notification SPL Medicxi Partnership 08/04/24 download Created with Sketch. 145.32KB Share SPL Starpharma and Medicxi Partnership Petalion Therapeutics 08/04/24 PRICE SENSITIVE download Created with Sketch. 190.59KB Share SPL S&P DJI Announces March 2024 Quarterly Rebalance 01/03/24 PRICE SENSITIVE download Created with Sketch. 120.24KB Share SPL Half Yearly Report and Accounts 28/02/24 PRICE SENSITIVE download Created with Sketch. 1.33MB Share SPL VivaGel BV US FDA Appeal Outcome 19/02/24 PRICE SENSITIVE download Created with Sketch. 209.89KB Share SPL Application for quotation of securities - SPL 06/02/24 download Created with Sketch. 17.05KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/01/24 PRICE SENSITIVE download Created with Sketch. 344.69KB Share SPL Viraleze shows antiviral efficacy in COVID-19 patients 29/01/24 PRICE SENSITIVE download Created with Sketch. 302KB Share SPL VivaGel BV sales and distribution agreement MENA region 22/01/24 PRICE SENSITIVE download Created with Sketch. 238.74KB Share SPL DEP cabazitaxel data presentation at ASCO GI cancer meeting 19/01/24 download Created with Sketch. 1.61MB Share SPL Notification of cessation of securities - SPL 12/01/24 download Created with Sketch. 21.61KB Share SPL Final Director's Interest Notice - J Fairley 12/01/24 download Created with Sketch. 230KB Share SPL Appendix 3X - Cheryl Maley 12/01/24 download Created with Sketch. 232.31KB Share SPL Notification regarding unquoted securities - SPL 12/01/24 download Created with Sketch. 27.46KB Share SPL Application for quotation of securities - SPL 21/12/23 download Created with Sketch. 26.21KB Share SPL Positive DEP docetaxel Phase 2 results 19/12/23 PRICE SENSITIVE download Created with Sketch. 303.21KB Share SPL Change in Director's Interest Notice - J Fairley 08/12/23 download Created with Sketch. 162.64KB Share SPL Notification regarding unquoted securities - SPL 08/12/23 download Created with Sketch. 26.7KB Share SPL Starpharma to present DEP at Radiopharmaceuticals Summit 06/12/23 download Created with Sketch. 3.64MB Share SPL AGM Results 29/11/23 download Created with Sketch. 160.38KB Share SPL AGM Chairman's address and CEO presentation 29/11/23 PRICE SENSITIVE download Created with Sketch. 7.75MB Share SPL Application for quotation of securities - SPL 15/11/23 download Created with Sketch. 26.31KB Share SPL Notice of Annual General Meeting 2023 - Clarification 15/11/23 download Created with Sketch. 199.29KB Share SPL Starpharma Presents at Bell Potter Conference 14/11/23 download Created with Sketch. 2.63MB Share SPL Application for quotation of securities - SPL 10/11/23 download Created with Sketch. 26.21KB Share SPL Starpharma announces new CEO, Ms Cheryl Maley 10/11/23 PRICE SENSITIVE download Created with Sketch. 238.8KB Share SPL Notification regarding unquoted securities - SPL 06/11/23 download Created with Sketch. 26.34KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/10/23 PRICE SENSITIVE download Created with Sketch. 722.62KB Share SPL Notice of Annual General Meeting/Proxy Form 27/10/23 download Created with Sketch. 14.21MB Share SPL SPL to present DEP radiotheranostics at Wilsons Conference 26/10/23 download Created with Sketch. 2.04MB Share SPL Starpharma receives $7.2 million R&D Tax Incentive refund 23/10/23 PRICE SENSITIVE download Created with Sketch. 195.31KB Share SPL Ceasing to be a substantial holder 23/10/23 download Created with Sketch. 382.58KB Share SPL Change in substantial holding 20/10/23 download Created with Sketch. 178.85KB Share SPL Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer 18/10/23 PRICE SENSITIVE download Created with Sketch. 386.76KB Share SPL DEP irinotecan IO/PARP combination data presented at AACR 16/10/23 download Created with Sketch. 508.19KB Share SPL DEP theranostic presented at international oncology meeting 16/10/23 download Created with Sketch. 683.45KB Share SPL DEP irinotecan clinical data presented at AACR meeting 16/10/23 PRICE SENSITIVE download Created with Sketch. 1.59MB Share SPL Ceasing to be a substantial holder 16/10/23 download Created with Sketch. 115.13KB Share SPL Application for quotation of securities - SPL 09/10/23 download Created with Sketch. 26.19KB Share SPL Change in Director's Interest Notice - J Fairley 06/10/23 download Created with Sketch. 297.01KB Share SPL Notification of cessation of securities - SPL 06/10/23 download Created with Sketch. 21.61KB Share SPL 2023 Annual General Meeting Date 02/10/23 download Created with Sketch. 212.03KB Share SPL Ceasing to be a substantial holder 29/09/23 download Created with Sketch. 188.92KB Share SPL DEP irinotecan combination data presentation 27/09/23 PRICE SENSITIVE download Created with Sketch. 244.62KB Share SPL VIRALEZ UK COVID-19 Clinical Study Completes Recruitment 25/09/23 PRICE SENSITIVE download Created with Sketch. 211KB Share SPL Change in substantial holding 20/09/23 download Created with Sketch. 685.22KB Share SPL Positive DEP irinotecan clinical results presentation 13/09/23 PRICE SENSITIVE download Created with Sketch. 305.62KB Share SPL Change in substantial holding 12/09/23 download Created with Sketch. 181.87KB Share SPL Company Secretary Appointment/Resignation 28/08/23 download Created with Sketch. 211.6KB Share SPL Corporate Governance Statement 25/08/23 download Created with Sketch. 620.78KB Share SPL Appendix 4G - Corporate Governance Statement 24/08/23 download Created with Sketch. 390.09KB Share SPL App 4E/Annual Report to shareholders 24/08/23 PRICE SENSITIVE download Created with Sketch. 4.53MB Share SPL Change in substantial holding 17/08/23 download Created with Sketch. 331KB Share SPL Change in substantial holding 17/08/23 download Created with Sketch. 183.33KB Share SPL Change in substantial holding 15/08/23 download Created with Sketch. 171.85KB Share SPL SPL to receive $6.5M from Mundipharma and VivaGel BV rights 14/08/23 PRICE SENSITIVE download Created with Sketch. 200.3KB Share SPL Change in substantial holding 02/08/23 download Created with Sketch. 5.32MB Share SPL Partnered Program Update 31/07/23 PRICE SENSITIVE download Created with Sketch. 217.74KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/07/23 PRICE SENSITIVE download Created with Sketch. 731.65KB Share SPL Trading Halt 28/07/23 PRICE SENSITIVE download Created with Sketch. 218.36KB Share SPL Pause in Trading 28/07/23 PRICE SENSITIVE download Created with Sketch. 114.3KB Share SPL Starpharma partners with UQ to advance DEP radio pipeline 26/07/23 PRICE SENSITIVE download Created with Sketch. 216.87KB Share SPL DEP HER2-radiodiagnostic shows imaging benefits 21/07/23 PRICE SENSITIVE download Created with Sketch. 293.92KB Share SPL Notification of cessation of securities - SPL 07/07/23 download Created with Sketch. 21.71KB Share SPL Clinical Trial Update 27/06/23 PRICE SENSITIVE download Created with Sketch. 213.03KB Share SPL Life Sciences Investor Forum Presentation 23/06/23 download Created with Sketch. 6.12MB Share SPL Starpharma to present at Life Sciences Investor Forum 22/06/23 download Created with Sketch. 214.29KB Share SPL AZD0466 Clinical Data Presented by AstraZeneca EHA Congress 14/06/23 download Created with Sketch. 774.67KB Share SPL Starpharma CEO to retire in 2024 09/06/23 PRICE SENSITIVE download Created with Sketch. 178.72KB Share SPL VIRALEZE Nasal Spray Approved in Malaysia 05/06/23 PRICE SENSITIVE download Created with Sketch. 225.85KB Share SPL Application for quotation of securities - SPL 05/05/23 download Created with Sketch. 26.53KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 401.33KB Share SPL HER2-targeted DEP SN38 ADC outperforms in HER2 cancer model 26/04/23 PRICE SENSITIVE download Created with Sketch. 302.96KB Share SPL AZD0466 active in small cell lung cancer patient models 20/04/23 download Created with Sketch. 3.03MB Share SPL DEP cabazitaxel Ph 2 trial completes enrolment & treatment 17/04/23 download Created with Sketch. 232.51KB Share SPL Commencement of CFO and Company Secretary 03/04/23 download Created with Sketch. 288.56KB Share SPL Starpharma presents at ASX Small and Mid-Cap Conference 22/03/23 download Created with Sketch. 6.82MB Share SPL Application for quotation of securities - SPL 17/03/23 download Created with Sketch. 26.19KB Share SPL CFO and Company Secretary Appointment 03/03/23 download Created with Sketch. 200.63KB Share SPL Interim Report and Half-Year Financial Results 28/02/23 PRICE SENSITIVE download Created with Sketch. 1.2MB Share SPL Dr Russell Basser appointed as director and Appendix 3X 20/02/23 download Created with Sketch. 374.97KB Share SPL Change in substantial holding 10/02/23 download Created with Sketch. 187.43KB Share SPL Change in substantial holding 10/02/23 download Created with Sketch. 190.19KB Share SPL Application for quotation of securities - SPL 01/02/23 download Created with Sketch. 26.48KB Share SPL Appointment of Company Secretary 01/02/23 download Created with Sketch. 192.34KB Share SPL Dr Russell Basser appointed as non-executive director 31/01/23 download Created with Sketch. 220.08KB Share SPL Quarterly Activities Report & Appendix 4C 30/01/23 PRICE SENSITIVE download Created with Sketch. 329.34KB Share SPL Response to ASX Query Letters 12/01/23 PRICE SENSITIVE download Created with Sketch. 504.84KB Share SPL Starpharma receives $7.1M R&D tax incentive refund 23/12/22 PRICE SENSITIVE download Created with Sketch. 200.28KB Share SPL Resignation of CFO / Company Secretary 21/12/22 download Created with Sketch. 207KB Share SPL VIRALEZE Nasal Spray Registered in Indonesia 14/12/22 PRICE SENSITIVE download Created with Sketch. 229.62KB Share SPL Positive AZD0466 clinical data presented by AstraZeneca 13/12/22 PRICE SENSITIVE download Created with Sketch. 258.89KB Share SPL VIRALEZE Post-Market Clinical Study in COVID-19 Patients 08/12/22 download Created with Sketch. 198.55KB Share SPL Change in Director's Interest Notice - J Fairley 05/12/22 download Created with Sketch. 275.72KB Share SPL Notification regarding unquoted securities - SPL 05/12/22 download Created with Sketch. 25.23KB Share SPL Retirement of non-executive Director 30/11/22 download Created with Sketch. 343.84KB Share
12.0¢
(20min delay)
